Clinical Trials

47 enrolled

Small Cell Lung Carcinoma

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

BreastGastrointestinalThoracic

260 enrolled

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

60 enrolled

Advanced Non-Small Cell Lung Cancer

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

108 enrolled

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT06256055 2024-07-24

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

GastrointestinalHead & NeckThoracic

68 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03921671 2024-05-29

RELEVENT

60 enrolled

Neoplasm Metastasis, Thymoma

NCT06406673 2024-05-09

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

70 enrolled

Extensive Small Cell Lung Cancer

NCT04622007 2024-04-30

KICKSTART

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06391008 2024-04-30

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

44 enrolled

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

NCT04913415 2024-04-25

A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery

160 enrolled

Lung Neoplasms

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

264 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04808752 2024-04-22

ACHIEVE

63 enrolled

Lung Neoplasms

NCT05735028 2024-04-17

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

8 enrolled

Lung Neoplasms

NCT06364046 2024-04-15

Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC

56 enrolled

Carcinoma, Small Cell Lung Carcinoma

NCT05240131 2024-04-12

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

88 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06150131 2024-04-12

Exercise Intervention After Lung Cancer Surgery

90 enrolled

Rehabilitation After Lung Cancer Surgery

NCT05519293 2024-04-11

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

76 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05552781 2024-04-11

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

76 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06356701 2024-04-10

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

120 enrolled

Lung Neoplasms

NCT06357598 2024-04-10

PILOT

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05888584 2024-04-09

LungI-ACT

100 enrolled

Lung Neoplasms

NCT02324283 2024-04-05

Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia

80 enrolled 9 charts

Lung Neoplasms

NCT06158971 2024-04-04

Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation

10 enrolled

Lung Neoplasms

NCT04487756 2024-04-03

VENEZO-LUNG

20 enrolled

Small Cell Lung Carcinoma

NCT06344962 2024-04-03

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341660 2024-04-02

To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06339242 2024-04-01

A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

NSCLC

NCT03893539 2024-03-29

Clinical Utility for Ion Endoluminal System

365 enrolled

Lung Diseases, Lung Neoplasms

NCT04209868 2024-03-29

ParaSOL

Phase 2/3 Unknown

100 enrolled

Thoracic Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06334757 2024-03-28

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

46 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT06332287 2024-03-27

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

25 enrolled

Phase EARLY_PHASE1 Unknown

NSCLC

NCT06106152 2024-03-26

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

20 enrolled

Advanced Lung Cancer

NCT06331650 2024-03-26

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02619448 2024-03-25

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

NSCLC

NCT03322072 2024-03-20

GPS

28 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05649046 2024-03-18

PREVALUNG*

160 enrolled

Lung Neoplasms, Bronchitis, Chronic, Plaque, Atherosclerotic

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

110 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT05801133 2024-03-15

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

41 enrolled

Lung Neoplasms

NCT05004974 2024-03-12

Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer

20 enrolled

Advanced Non Small Cell Lung Cancer

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms